bit.bio Secures Foundational United States Patent for opti-oxTM, its Cell Programming Technology That Uses Genomic Safe Harbour Sites
bit.bio, the company coding human cells for novel cures, has secured a foundational U.S. patent for opti-ox, its precision cell programming and manufacturing technology. opti-ox uses a dual genomic safe...

